Skip to main content
Top

Classic Hodgkin lymphoma in a patient with Behçet’s disease: a case report and review of the literature

Abstract

Introduction

Behçet’s disease (BD) is a chronic relapsing inflammatory vasculitis associated with an increased risk of malignancy, particularly hematologic cancers. However, reports of Hodgkin lymphoma (HL) in BD remain rare.

Case report

A 21-year-old female with BD on long-term glucocorticoid therapy who presented with fatigue, dyspnea, and oral ulcerations in the setting of an enlarging anterior mediastinal mass. Laboratory evaluation revealed microcytic anemia, leukocytosis, thrombocytosis, and elevated inflammatory markers. Infectious and autoimmune evaluations were unrevealing for other etiologies. Biopsy of the mediastinal mass confirmed Epstein-Barr virus (EBV)-positive classic HL, and PET-CT demonstrated FDG-avid nodal involvement. The patient was discharged with oncology follow-up for planned chemoradiation.

Discussion

BD and HL are shown to have minimal associations in the literature, and thus, this review illustrates a rare but important association between BD and HL, possibly mediated by immune dysregulation and chronic immunosuppression. Clinicians should maintain a high index of suspicion for malignancy in BD patients on long-term steroids presenting with atypical or progressive findings, such as a mediastinal mass, to enable prompt diagnosis and treatment.
Title
Classic Hodgkin lymphoma in a patient with Behçet’s disease: a case report and review of the literature
Authors
Matthew Coulter
Vicente J. Velez
Publication date
10-12-2025
Publisher
Springer International Publishing
Published in
Clinical Rheumatology
Print ISSN: 0770-3198
Electronic ISSN: 1434-9949
DOI
https://doi.org/10.1007/s10067-025-07869-z
This content is only visible if you are logged in and have the appropriate permissions.

Keynote webinar | Spotlight on advances in lupus

Systemic lupus erythematosus is a severe autoimmune disease that can cause damage to almost every system of the body. Learn more about novel biomarkers for diagnosis and monitoring, and familiarize yourself with current and emerging targeted therapies.

Prof. Edward Vital
Prof. Ronald F. van Vollenhoven
Watch now
Video

Elevate your expertise in aplastic anemia (Link opens in a new window)

Transform the way you care for your patients with aplastic anemia with our 3-module series using real-world case studies and expert insights. Discover why early diagnosis matters, explore the benefits and risks of current treatments, and develop tailored approaches for complex cases. 

Supported by:
  • Pfizer
Developed by: Springer Health+ IME
Learn more
Image Credits
FDG PET-CT of patient with Behçet disease and Hodgkin lymphoma/© 2025, Matthew Coulter et al, under exclusive licence to International League of Associations for Rheumatology (ILAR), Clin Rheumatol, Lupus concept/© (M) Vitalii But / stock.adobe.com / Generated with AI, Aplastic Anemia/© Springer Healthcare IME